Rowan (ROWAN) has signed a memorandum of understanding (MOU) with Neurive, a leading company in digital healthcare. Through this partnership, the two companies aim to combine their respective technologies and expertise to jointly develop innovative healthcare solutions and enhance their competitiveness in the global market. 

Rowan specializes in providing AI-based health management solutions, focusing on personalized health management and predictive analytics to improve users' well-being. Rowan's flagship product, 'SuperBrain,' is an AI-powered brain health management solution that helps users improve cognitive function and maintain brain health. Neurive, on the other hand, develops cutting-edge life science technologies and digital healthcare platforms. Notably, Neurive's hearing care solution, 'SoriClear,' has significantly contributed to improving the quality of life for people with hearing impairments and the elderly. With the signing of this MOU, the two companies will leverage their strengths to provide differentiated healthcare services.

Under this agreement, Rowan's AI technology will be combined with Neurive's data analysis capabilities to develop more accurate and efficient health management solutions. Additionally, they plan to jointly build a user-friendly healthcare platform, making services more accessible to users. The companies will also formulate a strategy for expanding into global markets, offering customized solutions tailored to the unique characteristics of different countries.

Rowan's CEO commented, "This MOU marks a significant milestone in the digital healthcare industry and is expected to provide users with a better healthcare experience." Neurive's CEO also expressed confidence, saying, "Our collaboration with Rowan will enable us to introduce innovative technologies and strengthen our presence in the global market." He added that the integration of SuperBrain and SoriClear would offer users a more comprehensive and efficient healthcare solution.

Both companies plan to strengthen their joint research and development (R&D) efforts, actively pursue new product launches and marketing activities, and hold regular collaborative meetings to monitor project progress and continuously deliver results.